| 
Results for peptide therapeutics. Search took 0.10 seconds.
Gene Therapy for Leber's Congenital Amaurosis (LCA)
in The Biotech Weblog, on October 26, 2009
...nical vector production facility at Children’s Hospital’s Center for Cellular and Molecular Therapeutics (CCMT), directed by Fraser Wright, Ph.D., manufactured the vector.
Here's a video showing th...
Aerosol Measles Vaccine
in The Biotech Weblog, on October 21, 2009
© Dave Haygarth Researchers have developed a new method for the delivery of measles vaccine that allows the patient to inhale a finely-powdered form of the vaccine. Attenuated measles virus was mixed with high-pressure carbon dioxide to produce microscopic bubbles and droplets, which are t...
BioAccelerate NYC Prize To Fund Translational Research
in The Biotech Weblog, on October 18, 2009
...New York.
The BioAccelerate NYC competition is looking to fund translational research related to therapeutics, devices and diagnostics that can direct clinical care. As a key part of its evaluation...
Victoza® (liraglutide) Received EU Marketing Authorization
in Daily Diabetic, on July 6, 2009
...received narketing authorization by the EU.
Victoza is the first once-daily human glucagon-like peptide-1 (GLP-1) analog developed for the treatment of type 2 diabetes and is now authorized in all ...
Diabetes Drug Januvia May Trigger Pancreatitis, Pancreatic Cancer
in Daily Diabetic, on April 30, 2009
...a member of a new class of drugs that enhance the actions of the gut hormone known as glucagon-like peptide 1 (GLP-1), which has been shown to be effective in lowering blood sugar in people with type ...
Stem Cell Transplantation Benefits Type 1 Diabetics
in Daily Diabetic, on April 14, 2009
...tion and function and chronic complications of type 1 diabetes mellitus (DM), and the higher the C-peptide levels (a byproduct of insulin production, made up of amino acids), the lower the incidence o...
Google to Invest in Biotechnology
in The Biotech Weblog, on April 3, 2009
...in View, Calif.
Google is open to funding biotechnology start-ups. "If we find an interesting therapeutics company, we'd be happy to put down a term sheet," Maris said.
Read the entire...
Cinnamon May Improve Blood Sugar Levels
in Daily Diabetic, on February 21, 2009
...sulin levels, the hormone responsible for controlling blood sugar levels, and increased levels of a peptide reported to work by delaying the emptying of the stomach (gastric emptying).
Despite the in...
Nominations Open for the Biotech Humanitarian Award
in The Biotech Weblog, on January 13, 2009
...r, philanthropist or educator - whose work in biotechnology made significant impact in the areas of therapeutics, food and agriculture, or industrial or environmental applications.
Qualified nominees...
Stress During Childhood Linked to Increased Allergy Risks
in Allergies, on September 2, 2008
...rgies.
Blood samples from 234 children showed increased blood concentrations of the stress-related peptide VIP (vasoactive intestinal polypeptide) as well as an increased concentration of immune mark...
Nanotubes Punching Holes in Cancer
in Nanotechbuzz, on August 28, 2008
...icity, and more effective treatment of cancer. The future of cancer care will involve more targeted therapeutics on molecular and nano-mechanical levels. Source: Stanford News
...
Fighting Cancer with Magnetic Nanoparticles
in Nanotechbuzz, on July 21, 2008
...mbination of the two. The researchers at Georgia Tech are also working with other groups to see how peptide-directed gold nanoparticles and nanohydrogels might also be used to combat cancer. Source: ...
Diet and Type 2 Diabetes
in Daily Diabetic, on July 15, 2008
...o significant reductions in many diabetes related factors, such as insulin resistance, fasting C-peptide , fasting proinsulin, fasting blood glucose, fasting triglycerides, and fasting cholester...
Cancer Detecting Nanoparticles
in The Biotech Weblog, on May 30, 2008
... Scientists have designed peptide-coated iron oxide nanoparticles that can seek out tumor cells and make detection using magnetic resonance imaging possible.
The team created peptide-coated iron...
Instantly Stop Bleeding
in Nanotechbuzz, on May 29, 2008
...certain individuals who have bleeding disorders such as hemophilia .
A company called Arch Therapeutics has licensed special technology from MIT and is developing a material that may instant...
Secretions of South American Frog: New Hope for Diabetes Treatment?
in Daily Diabetic, on March 6, 2008
... vital hormone which is deficient in diabetes sufferers.
Scientists made an artificial copy of the peptide, or protein building block, and showed that it could be used to boost insulin production ...
(Pro3)GIP Injections May reverse Obesity and Diabetes
in The Biotech Weblog, on January 7, 2008
... Scientists have identified a gastric inhibitory polypeptide (GIP) receptor antagonist called (Pro3)GIP , which has been demonstrated in an animal model to be capable of promoting weight loss, imp...
Hormone Blocker Found May Prevent Obesity and Diabetes
in Daily Diabetic, on January 4, 2008
...The hormone called gastric inhibitory polypeptide (GIP) receptor blockade has been found capable of promoting weight loss, improving insulin resistance and reversing diabetes in an animal model.
...
Top Ten Cool Hedge Fund Moves
in The Hedge Funds Weblog, on January 4, 2008
...ipotle Mexican Grill
Firm: Tremblant Capital Group
Profit: $95 million
Top Trade #10: United Therapeutics Corp.
Firm: Shunway Capital Partners
Profit: $73 million
...
Peptide Drug Aimed at Two Bioterror Agents
in The Biotech Weblog, on December 21, 2007
... a drug candidate against potential bioterror agents, Hendra and Nipah viruses. The compound is a peptide (protein) related to a parainfluenza virus that appeared to block "pseudo" He...
More Evidence that Alzheimer's is A Type 3 Diabetes
in Daily Diabetic, on November 30, 2007
...shes, "the insulin receptors disappeared from their surfaces."
This just means that new therapeutics in both diabetes and Alzheimer's can potentially be developed in lieu of such findi...
Enhanced HIV Vaccine, Helped Monkeys Kick AIDS-like Symptoms
in Straightfromthedoc, on November 28, 2007
... Penn.:
"DNA vaccine technology has great promise for the development of vaccines and immune therapeutics for a variety of infectious diseases and cancers.
While previous studies have establis...
Cannabis Compound Can Potentially Fight Metastatic Breast Cancer
in Straightfromthedoc, on November 25, 2007
...tive it is still considered a Schedule 1 drug.
Findings appear in the journal Molecular Cancer Therapeutics .
Source: California Pacific Medical Center Research Institute (a pdf file)
...
Progression of Parkinson's Disease May Be Prevented by Peptide Therapy
in Straightfromthedoc, on November 25, 2007
...A peptide that can reverse the biochemical, cellular and anatomical changes that occur in the brains of mice with Parkinson's disease (PD) has been successfully used in preventing the dis...
Fish Oil, Good Supplemental Treatment for Lupus
in Straightfromthedoc, on November 13, 2007
...al function.
According to Stephen Wright, MD, specialist registrar in rheumatology, department of therapeutics and musculoskeletal education & research unit, Queen's University of Belfast, ...
Diabetes Drug Diamyd™ Passed Phase II of Type 1 Diabetes Trial
in Daily Diabetic, on October 30, 2007
...ived Diamyd™ produced approximately twice as much meal stimulated insulin (as measured by C-peptide ) 15 months after the first treatment as compared to the placebo group (p ~ 0.01). Preserving ...
Tuberculosis Drug Candidate SQ109 Granted Orphan Drug Status
in The Biotech Weblog, on October 30, 2007
... National Cancer Institute /NIAID Inter-Institute Program for the Development of AIDS-related Therapeutics. NIAID licensed the SQ109 technology to Sequella in March 2006 under a Cooperative Rese...
Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer
in The Biotech Weblog, on October 25, 2007
...py using flavopiridol (an investigational anti-cancer agent that also boosts the effects of other therapeutics including cisplatin) with cisplatin (a platinum compound) for women with platinum-resi...
Tea Helps Strengthen Hips
in Well Woman Blog, on October 17, 2007
...otentially helpful," said Paul Brandt, an associate professor of neuroscience and experimental therapeutics at Texas A&M Health Science Center College of Medicine. "One or two cups of te...
Novel D-Peptides More Potent Against HIV
in The Biotech Weblog, on October 11, 2007
... Scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class.
"Our ...
Alzheimer's Disease: Type 3 Diabetes?
in Daily Diabetic, on September 27, 2007
...
This fundamental connection between the two conditions offers hope for the development of future therapeutics.
Source: Science Daily ; FASEBJ Abstract
...
Exenatide, Better than Insulin Glargine
in Daily Diabetic, on September 22, 2007
...owed significant improvements in beta-cell function as measured by arginine and glucose induced C-peptide (a peptide associated with insulin production) secretion during a glucose clamp procedu...
Red Wine Diet
in Celebrate Wine, on September 19, 2007
...s published by avery (326 pages, $15.95). Corder is a cardiovascular expert and professor of therapeutics at London's William Harvey Research Institute....
Human Source of Stem Cells With Potential To Repair Muscle Damaged by Disease or Injury
in The Biotech Weblog, on September 5, 2007
Scientists have isolated stem cells from blood vessels (known as myoendothelial cells) which can be differentiated in the laboratory into muscle, bone and cartilage cells and are thus suitable for use as a potential therapy for muscle injuries and diseases including heart attack and muscle dystro...
The Gut has Glucose Receptors Too
in Daily Diabetic, on September 4, 2007
...transporter 1 and Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1 .]...
Symposium: Regulatory RNA in Biology and Human Health
in The Biotech Weblog, on August 28, 2007
...and biogenesis of small regulatory RNAs and how this is being applied to create a new generation of therapeutics and diagnostics.
The main topics to be discussed in this symposium includes:
Mech...
Elixir Pharma's Type 2 Diabetes Drug Mitiglinide Enters Phase III Clinical Trial
in Daily Diabetic, on August 22, 2007
...cal Advisory Board:
"There continues to be a tremendous unmet medical need in the U.S. for therapeutics that can be used alone or in combination with other drugs to provide patients with type 2...
Pepfactant® Switchable Peptide Surfactant
in The Biotech Weblog, on August 22, 2007
...ensland)
Researchers have developed Pepfactant® , a biological detergent or surfactant made from peptides which can be "switched on" or "switched off" depending on its intended a...
Anti-Diabetes Drug Candidate Liraglutide Improves Glucose Control and Lowers Body Weight
in The Biotech Weblog, on August 21, 2007
... Liraglutide is a once-daily human analogue of the naturally occurring hormone glucagon -Like Peptide-1 (GLP-1), and works by stimulating the release of insulin only when glucose levels become t...
About Generex's Oral-Lyn™ Oral Insulin Spray
in Daily Diabetic, on August 17, 2007
...s are yielding promising results, as was recently published in Diabetes Technology & Therapeutics (article title: Comparison of Oral Insulin Spray and Subcutaneous Regular Insulin at Mealtime i...
DNA Vaccine Against Multiple Scclerosis Appears Safe
in The Biotech Weblog, on August 15, 2007
...
Results of a clinical trial funded by Bayhill Therapeutics, Inc. shows that BHT-3009 , a newly developed DNA vaccine against multiple sclerosis appears safe and may produce beneficial changes...
Pollinex Quattro Hay Fever Vaccine Clinical Studies on Hold
in Allergies, on August 7, 2007
... Late last year, there were high hopes on Allergy Therapeutics ' new version of ragweed allergy vaccine called Pollinex Quattro , which has entered the last stages of development. Unlik...
Dynavax Technologies Corp. Received $30 Million for Allergy Franchise
in Allergies, on July 25, 2007
...verse immunologic response in allergic diseases.
Given the market opportunities associated with therapeutics targeting these areas, Deerfield has partnered with us in this venture and agreed to shar...
Brustvergroeßerung, natuerlich, mit Stammzellen aus eigenem Fettgewebe
in Das Gesundheits-Weblog, on 10.07.07
...ntnommen. Aus diesem werden mit einem vom kalifornischen Biotechnologieunternehmen Cytori Therapeutics entwickelten Gerät innerhalb von nur einer Stunde Fett-Stammzellen isoliert und angereichert. Ans...
Rheuma und Arthritis, Gelenkentzuendung: neuer Test, Diagnose beim Hausarzt einfacher
in Das Gesundheits-Weblog, on 10.07.07
...ibt einen sehr speziellen "Marker": Antikörper gegen CCP (sog. zyklische citrullierte Peptide). In dem Labortest, der von den gesetzlichen Kassen bezahlt wird, werden beide Marker bestimmt: ...
BYETTA® Can Sustain Blood Glucose Control in Type 2 Diabetics
in Daily Diabetic, on July 2, 2007
...es. BYETTA® exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in c...
Natürlicher HIV-Hemmstoff entdeckt: neue Klasse von AIDS-Medikamenten ?
in Das Gesundheits-Weblog, on 27.06.07
...rt. Weiterhin fanden sie, dass einige wenige Aminosäureaustausche in der Sequenz dieses Peptides, als VIRIP (VIRus-Inhibitorisches-Peptid) bezeichnet, die Wirksamkeit gegen HIV-1 um etwa das 100-fache...
Liraglutide: Novo Nordisk Diabetes Drug, Better Than Insulin Therapy?
in Daily Diabetic, on June 21, 2007
...ulin glargine.
A once-daily human analogue of the naturally occurring hormone glucagon -Like Peptide-1 (GLP-1), liraglutide works by stimulating the release of insulin only when glucose level...
Protein May Prevent Eye Damage in Preemies
in Straightfromthedoc, on June 20, 2007
...s for retinopathy of prematurity.
According to Dr. Maria B. Grant, a professor of pharmacology and therapeutics at UF's College of Medicine:
"We've identified a protein that is part of...
How Gastric Bypass Surgery Gets Rid of Diabetes: Welsh Medics Will Take a Look
in Daily Diabetic, on June 4, 2007
...ogether with Dr Jeffrey Stephens are focusing attention on a protein known as glucagon Like Peptide 1 (GLP-1) - a protein produced in the small intestine.
Find more details from the full repo...
PTC124 Drug Candidate Against Duchenne Muscular Dystrophy and Other Genetic Diseases
in The Biotech Weblog, on April 25, 2007
Scientists report of a new prototype drug, designed to treat Duchenne muscular dystrophy but which may be useful in the treatment of up 1800 different genetic diseases. The drug, called PTC124 , has restored muscle function in mice trials.
Normal cells assemble amino acids into protein molecu...
Naturally Occurring Peptide in Human Blood Can Block HIV
in Straightfromthedoc, on April 24, 2007
...e been able to identify a relatively abundant molecule in the human blood -called VIRUS-INHIBITORY PEPTIDE or VIRIP - which has been found to be effective in blocking HIV-1.
Moreover, they showe...
ADHD Children Who Start on Strattera® More Likely to Change Therapies, Study Says
in Straightfromthedoc, on April 19, 2007
...ere initially used.
Such were the results of a study conducted by pharmacy benefit manager Prime Therapeutics LLC (Prime) .
In lieu of such results, Prime has developed programs that promote the u...
Snake Venom Toxin Inhibits Human Prostate Cancer Cell Growth
in The Biotech Weblog, on April 16, 2007
... A study published in a recent issue of Molecular Cancer Therapeutics report on the effectiveness of the snake venom toxin (SVT) Vipera lebetina turanica in the inhibition of androgen -i...
Merck Licenses Coley Pharma's VaxImmune for $4 Million
in The Biotech Weblog, on April 13, 2007
... infectious disease and biowarfare applications.
Source: Coley Pharmaceutical
Photo: TLR Therapeutics, Coley Pharmaceuticals ...
Something to Watch
in The Hedge Funds Weblog, on March 30, 2007
...Interesting article here; Osiris Rises on Heart-Treatment News .
Investors bid up Osiris Therapeutics stock by 13.6% to $20.33 per share in early trading on the Nasdaq on March 26 after the company&...
Pregnancy and Back Pain
in Well Woman Blog, on March 15, 2007
... reports on a recent study:
The study, published in the Journal of Manipulative and Physiological Therapeutics, says despite the high prevalence of musculoskeletal pain during pregnancy, few women i...
Novel Pulsed Microjet System for Needle-Free Delivery of Protein Drugs
in The Biotech Weblog, on March 12, 2007
...ly a 12 billion needle injections are performed every year for the delivery of vaccines and protein therapeutics such as insulin , growth hormone and erythropoietin (a red blood cell booster).
R...
RAMP1: The Protein that Promotes Migraine
in Straightfromthedoc, on March 12, 2007
...is protein seem to "turn up the volume" of a nerve cell receptor's response to a neuropeptide - called CGRP (calcitonin gene-related peptide) - that can cause migraines, which probably e...
Michael J. Fox to Deliver Keynote Address at 2007 BIO International Convention
in The Biotech Weblog, on March 2, 2007
....
The discussion will explore strategies and solutions to "de-risk" investment in novel therapeutics for the biotechnology industry and academia alike.
Read the full report .
...
Adipose-Derived Stem Cell Therapy for Cardiovascular Disease
in The Biotech Weblog, on February 9, 2007
...
Cytori Therapeutics , a biotech firm developing stem and regenerative cell therapies for cardiovascular diseases treated their first patient in a hospital in Spain as part of Cytori's randomi...
Natural Fibre Oligo Fructose: Promising New Diet Product on Human Trial
in Straightfromthedoc, on February 6, 2007
...vious study with rats that the fiber increases the levels of a satiety hormone called glucagon-like peptide (GLP-1) in the body and increases a gene in the intestines that helps the body to create mor...
Peptide Vaccine with Toll-Like Receptor Agonists Against Breast Cancer
in The Biotech Weblog, on February 5, 2007
... In mouse trials, scientists have demonstrated the efficacy of a peptide vaccine against breast cancer. The vaccine includes toll-like receptor agonists as well as antibodies to blunt other aspects ...
Chromium Picolinate: Best Chromium Form to Clinically Benefit Diabetics
in Straightfromthedoc, on February 2, 2007
...d analysis of Chromium Picolinate , published in the current edition of Diabetes Technology & Therapeutics , confirms that chromium picolinate is effective in improving glycemic control a...
Evaluating Press Releases Before Buying Biotech Stocks
in The Biotech Weblog, on January 22, 2007
...you need?
Adam Feuerstein offers valuable insights in interpreting press releases , taking Point Therapeutics ' press release as a case in point.
...
Biotechnology in 2007
in The Biotech Weblog, on January 4, 2007
...echnology. Care to make predictions? In what areas do you think we'll make big progress on? New therapeutics? Economically feasible alternative energy sources? Novel technology in agriculture and ...
Blocking Apo E and Amyloid Beta Interaction to Target Alzheimer's Disease
in Straightfromthedoc, on December 23, 2006
...logy, Pathology and Psychiatry, the research team created a nontoxic, synthetic protein fragment or peptide that binds to apo E, preventing it from latching onto amyloid. Once deprived of its biochemi...
Biomarkers for Breast Cancer Metastasis
in The Biotech Weblog, on December 18, 2006
...ted . Although yet unidentified, scientists speculate that these proteins are thymosin beta-10 , a peptide that has already been associated with out-of-control growth and cell differentiation, and a...
Protein Biomarkers for Alzheimer's Disease
in The Biotech Weblog, on December 14, 2006
... aid in the early detection and diagnosis of AD, but also help in identifying and testing potential therapeutics.
[Image: Three-dimensional visualization of part of the spinal fluid protein bar code ...
Using RNAi Technology Against BSE and CJD
in The Biotech Weblog, on December 10, 2006
... Scientists may be on to a novel approach for the development of therapeutics against neurodegenerative diseases such as Bovine spongiform encephalopathy (BSE, also known as "mad cow dis...
